Comparison on different concentrations of ropivacaine for ultrasound-guided brachial plexus block via superior trunk approach and superficial cervical plexus block in arthroscopic shoulder surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPD-17010579

Enrollment

Unknown

Registered

2017-02-07

Start date

2017-02-08

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury of Rotator Cuff

Interventions

B group:0.25%ropivacaine

D group:0.35%ropivacaine

Eligibility

Sex/Gender

All

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: diagnosis of rotator cuff tear before surgery, stage I-II ASA, aged 45-75 years old, normal hepatic and renal functions and coagulation function.

Exclusion criteria

Exclusion criteria: severe heart, lung and brain comorbidities.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;dosage of opioids;dosage of sevoflurane;VAS scores at 6h after the surgery, 12h after the surgery;muscle strength grades at 6h after the surgery, 12h after the surgery;	—

Countries

China

Contacts

Public ContactGuo Jian-rong

Gongli Hospital, Second Military Medical University

guojianrongvvip@163.com+86 13918501254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026